Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |